, but CEA-like activity has been reported in serum in various non-neoplastic diseases, particularly of the liver and pancreas (Lo Gerfo, Krupey, and Hansen, 1971; Moore, Kupchik, Marcon, and Zamcheck, 1971; Moore, Dhar, Zamcheck, Keeley, Gottlieb, and Kupchik, 1972; Krupey, Wilson, Freedman, and Gold, 1972; Warner, Khoo, MacSween, Bankhurst, and Mackay, 1973 
through 5300 to 100%; equivalent findings were reported in a joint investigation (1972) on CEA in colonic cancer. Also, the amount of CEA detected was shown to be quantitatively greater when cancer had disseminated Laurence et al, 1972; Warner et al, 1973) . However there did not appear to be any association between morphological differentiation or histological type of the tumour and the detection of CEA in serum according to Laurence et al (1972) , and both squamous cell carcinoma and adenocarcinoma of the female reproductive tract were equally capable of resulting in raised CEA levels ).
The present study, using microradioimmunoassay of CEA in whole serum, examines the association of CEA-like activity in serum of patients with chronic disease of the liver and pancreas and relates levels of CEA to diagnostic subtypes and functional status of the liver. For brevity, 'CEA' will be used instead of 'CEA-like activity', recognizing that CEA may represent various components with different physicochemical properties.
Materials and Methods

OUTLINE OF STUDY
Levels of CEA in patients with diseases of the liver and pancreas were compared with those in healthy persons, miscellaneous patients in hospital ('hospital controls'), and patients with cancer of the digestive system. The specificity of the assay on whole serum was assessed by reassay of positive sera after extraction with perchloric acid. Levels of CEA were correlated with functional indices of liver disease including bromsulphalein retention (BSP), and levels of serum glutamic oxaloacetic transaminase (GOT), alkaline phosphatase (AP), and bilirubin. Chi square analysis was used to test differences for statistical significance.
PATIENTS
The study comprised 505 patients, grouped as follows. (a) Liver disease (131), including 115 with diffuse parenchymal disease and 16 with hepatoma complicating cirrhosis, diagnosed histologically; the former 115 were subgrouped, on the basis of results of biochemical tests, autoimmune serological studies, and liver biopsy (Mackay, 1971) , into alcoholic cirrhosis (35), active chronic hepatitis (58), cryptogenic cirrhosis (9), and primary biliary cirrhosis (13 bovine serum albumin in 0-01 M tris buffer replaced in duplicate tubes the goat antiserum to CEA; (2) normal human serum replaced in duplicate tubes the test serum; (3) a standard inhibition curve was constructed by adding known amounts per ml of CEA diluted in normal human serum. Under the conditions of our assay, the lowest amount of CEA detectable was 3 ng per ml; for the expression of results, the lower limit for positivity was taken as 5 ng per ml.
The following modification of the standard procedure of extraction of CEA from serum with perchloric acid was developed for small volumes of serum so as to minimize dilutional effects. Of 4M perchloric acid, 01 ml was slowly added to 0-3 ml of serum in a tube agitated in a Vortex mixer and the supernatant, after being held for one hour at 4°C and centrifuged at 4 OOOg for 10 minutes, was dialysed against repeated changes of distilled water for 48 hours; the retentate was tested by radioimmunoassay for carcinoembryonic antigen. (TABLE I) Of the 230 sera from healthy persons and hospital controls, seven (3 %) contained CEA and in six the level was low, 5-10 ng/ml; four were from blood donors and three from hospital controls diagnosed as cardiac failure, cerebral haemorrhage, and hysteria, respectively. Of the 129 sera from patients with non-malignant diseases of the liver (115) and pancreas (14), CEA was detected in 66 (51 %) but levels were mostly low, between 5 and 20 ng/ml. For 138 sera from patients with cancer of the digestive system, CEA was detected in 127 (92%), and in some 45 % the level exceeded 20 ng/ml. Z-gel assay, a level of 2 5 ng/ml has been defined as a positive result (Thomson et al, 1969; Lo Gerfo et al, 1971) , and there was an overall correlation of )EMBRYONIC ANTIGEN AND LIVER 83 to 86% between them (Sorokin, Kupchik, )N Zamcheck, and Dhar, 1972) . Laurence et al (1972) BSP retention and serum levels of GOT, equated a result of 12-5 ng/ml of CEA by their bilirubin were classified either as 'normal' 'double antibody' method with 2-5 ng/ml detected rmal' if the result was beyond the upper by the 'Z-gel' assay. Our present double antibody normal. For this analysis, patients were microradioimmunoassay detected 3 ng/ml, but we according to whether the level of CEA in used a 'cut-off' level of 5 ng/ml. The cut-off level rum was below or above 10 ng/ml. In the could be further raised to decrease 'background', considered, the incidence of levels of CEA but sensitivity is lost (Joint National Cancer Institute ng/ml was significantly greater in the of Canada/American Cancer Society Investigation, of abnormality of liver function ( Carcinoma of the pancreas is not readily differentiated from pancreatitis on the basis of CEA levels, but higher levels are more indicative of cancer. The value of CEA assay in the detection of hepatoma is slight because of the high frequency of positive results in cirrhosis.
A high incidence (some 50%) of CEA in patients with benign diseases of the liver and pancreas was reported by Lo Gerfo et al (1971) and Moore et al (1971) , although levels were lower than those in patients with cancer of the digestive system. Levels of CEA exceeding 2 5 ng/ml were detected in 40 of 88 patients with alcoholic liver disease but in none of 14 patients with non-alcoholic liver disease, and positive results correlated with alcoholic hyalin, hydropic degeneration, and fat in the liver . We found levels of CEA above 5 ng/ml in various forms of diffuse parenchymal liver disease, but the incidence and serum levels differed considerably according to the pathogenetic subtype, being greatest in alcoholic and cryptogenic cirrhosis and least in active chronic hepatitis. The magnitude of the CEA level correlated with the severity of the liver disease, as indicated by conventional tests of liver function, and the higher incidence of positive results in alcoholic and cryptogenic cirrhosis could be attributed to a greater impairment of function in these diseases.
The frequent detection of CEA in benign disease of the liver and pancreas poses the question of the specificity of the assay. Is CEA in effect being detected? Comparison of our results before and after extraction of CEA from serum with perchloric acid in patients with benign liver and pancreatic diseases indicates that positive tests for CEA remained even after extraction in 42 of 51 analyses. There was a moderate reduction in CEA level with sera extracted with perchloric acid, as compared with whole serum levels. The degree of reduction correlated with the dilution necessary for extraction, and the loss of CEA activity was therefore attributed to this. Other explanations would be interference with CEA activity by acid treatment, and loss of CEA activity via the dialysis membrane. Finally, in certain conditions, some of the CEA activity measured in our present assay might represent cross-reactive molecular configurations different from those measured in other assays; for example, in cases of 'active' ulcerative colitis, extraction and dialysis eliminated CEA-like activity detected in untreated serum (Khoo, Hunt, and Mackay, 1973) .
The reason for elevated levels of CEA or CEA-line substances in benign liver diseases remains uncertaik, as metabolism of CEA in the liver is yet to be known, and the following possibilities exist.
Production of CEA could accompany cellular regeneration in the liver; in cancer, CEA has been demonstrated on the glycocalyx of the tumour cell surface (Gold, Gold, and Freedman, 1968) .
Inflammation in the liver could give rise to glycoproteins with CEA-like activity.
Impaired liver function could result in failure of excretion of small amounts of CEA possibly produced under normal conditions.
We note that only small amounts of CEA are extractable from normal and cirrhotic livers, much less than amounts demonstrable in colonic cancer Khoo, Warner, Lie, and Mackay, 1973) ; however, there is said to be identical immunological reactivity between extracts of liver, extracts from hepatic metastases of colonic cancer, and sera of cirrhotic patients . Although our present results suggest that functional impairment of the liver is an important cause of raised levels of CEA in cirrhosis, other causes must be invoked to account for the finding in pancreatitis, and effects of inflammatory activity and cellular damage and regeneration remain to be assessed. Also the physicochemical nature of these CEA-reactive substances in non-neoplastic diseases of the liver and pancreas remains to be characterized.
